Segmental Re-inspection Matched Dye-Based Chromoendoscopy in IBD Surveillance
Surveillance colonoscopy in inflammatory bowel disease has long favored high-definition dye-based chromoendoscopy because it improves colorectal neoplasia detection compared with standard white light. The question behind HELIOS was sharper than the usual technology debate: is the gain driven by better mucosal contrast, or by the extra time spent looking carefully at each segment of colon? The trial answered that question by placing HD white-light endoscopy with segmental re-inspection beside HD chromoendoscopy, and by adding a single-pass HD white-light arm as a pragmatic control.
The design was multicenter and randomized, with adults aged 18 years or older who had inflammatory bowel disease, no active disease, and were scheduled for surveillance. Patients were assigned in a 2:2:1 ratio to one of three strategies: double-pass HD white-light endoscopy with segmental re-inspection of each colonic segment, HD chromoendoscopy, or single-pass HD white-light endoscopy. The primary endpoint was the colorectal neoplasia detection rate. The trial was powered around a non-inferiority framework, with a 10% margin between segmental re-inspection and chromoendoscopy, and with superiority of segmental re-inspection over single-pass HD white light also planned for evaluation.
The analysis included 563 patients in the per-protocol population. Colorectal neoplasia was detected in 10.3% of patients in the segmental re-inspection arm, with 24 of 234 patients affected, and in 13.1% in the chromoendoscopy arm, with 28 of 214 patients affected. The difference met the prespecified non-inferiority criterion, with a treatment difference of -2.8% and a lower 95% confidence limit of -7.8; the p value was less than 0.01. In practical terms, the double-pass white-light approach did not trail dye-based chromoendoscopy by enough to matter under the trial’s own statistical boundary.
One sentence captures the central result: segmental re-inspection was not worse than chromoendoscopy for neoplasia detection.
Inspection Time Appears to Carry Much of the Benefit
The study also examined the number of detected colorectal neoplasia cases per 10 minutes of withdrawal time. The rates were nearly identical between the segmental re-inspection and chromoendoscopy arms: 0.062 versus 0.058, with a p value of 0.83. That finding matters because it shifts the explanatory weight away from dye enhancement alone and toward the quality and duration of inspection. In other words, the mucosal benefit historically attributed to chromoendoscopy may, at least in this setting, be partly a function of a longer and more disciplined examination rather than a unique optical advantage.
This is clinically plausible. When the colon is repeatedly inspected segment by segment, subtle lesions have more chances to be seen, re-seen, and confirmed. Dysplasia in inflammatory bowel disease can be flat, pale, and easily lost in folds or post-inflammatory mucosal change, so a second look may recover lesions that a single pass misses. The HELIOS data support a workflow in which time on task may be as important as the imaging technology itself.
Single-Pass White Light Lagged Behind, but the Difference Did Not Reach Significance
The single-pass HD white-light arm yielded a colorectal neoplasia rate of 6.1%, with 7 of 115 patients affected. Compared with segmental re-inspection, this represented a lower detection rate, but the comparison did not cross the threshold for statistical significance. The treatment difference was 4.1%, with a 95% confidence interval from -2.2% to 9.6% and a p value of 0.19.
This is the most important cautionary note in the trial. The direction of effect favors doing more than a single pass, yet the data stop short of proving that re-inspection alone is superior to a standard HD white-light examination. The sample size for that specific comparison was smaller than the main active-arm contrast, and the confidence interval remains wide enough to leave genuine uncertainty about the magnitude of benefit.
What the Trial Means for Surveillance Practice
For endoscopists managing IBD surveillance, HELIOS offers a workable alternative to dye-based chromoendoscopy without sacrificing neoplasia detection. Segmental re-inspection with HD white light is easier to deploy in settings where dye spraying, added equipment, or workflow complexity limit chromoendoscopy use. The trial suggests that meticulous repeat inspection may capture much of the same diagnostic yield, especially when withdrawal time is deliberately extended and each segment receives a second pass.
The findings also carry a biological and procedural message. Neoplasia detection in long-standing colitis depends not only on image resolution but on the interaction between mucosal inflammation history, scarred architecture, and human attention. If the colon is surveyed too quickly, flat dysplastic lesions can disappear into the background of altered mucosa. If the same mucosa is examined again, lesion conspicuity rises because the observer gets another opportunity to interrogate areas that initially looked ordinary. HELIOS makes that principle visible in trial form.
There is no need to oversell the result. The comparison against chromoendoscopy succeeded on the prespecified non-inferiority question, but the study did not prove that segmental re-inspection is definitively superior to a single-pass white-light exam. Nor does it erase the possibility that some of chromoendoscopy’s advantage in prior studies has depended on operator behavior and inspection time rather than dye alone. What the trial does show, with direct clinical relevance, is that a disciplined HD white-light strategy can reach the same detection range as dye-based surveillance in this cohort.
For centers already using chromoendoscopy, the question becomes whether the added complexity is necessary for every surveillance program. For centers that struggle to implement dye spraying routinely, the data support a more accessible approach that preserves careful mucosal assessment. The remaining issue is not whether surveillance must remain meticulous; it is whether that meticulousness requires dye, or simply more time and a second look over the same colon.